╨╧рб▒с>■  13■   0                                                                                                                                                                                                                                                                                                                                                                                                                                                ье┴o@Ё┐М*bjbj p p ..oo3       ИТТТТТТТжоооо4т ж]ю········мооооооK RЭ bоiТ·····оТТ··°°°·ЖТ·Т·м°·м°(° ТТ ·ю аON╕1═╟оА" м-0]   вL  жжТТТТ  Т М··°·····оожжД*Дю жж* Salkovic-Petrisic M 1, Osmanovic J 1, Gr№nblat E 2, Riederer P 2, Hoyer S 3 1 Department of Pharmacology and Croatian Institute for Brain Research, Medical School, University of Zagreb, Zagreb, Croatia, 2 Department of Clinical Neurochemistry, Clinic for Psychiatry and Psychotherapy, Bayerische Julius-Maximilians- University of W№rzburg, W№rzburg, Germany, 3Department of Pathology, University of Heidelberg, Heidelberg, Germany. Pathological assemblies of amyloid beta (A▓) in the brain are thought of as the primary cause of all Alzheimer s disease (AD) forms, whereas other neuropathological changes being just downstream consequences. Among them, impairments in brain insulin receptor (IR) signaling have been implicated in the pathophysiology of the prevailing, sporadic late-onset AD (sAD) type. Our current work reviews evidence of brain insulin system dysfunction as a primary pathological event influencing tau protein and A▓ expression in streptozotocin-intracerebroventricularly (STZ-icv) treated rats proposed as an experimental model of sAD which is not related to gene manipulation. Gene and protein expression of insulin and IR (quantitative RT-PCR, ELISA), tyrosine kinase (TK) activity, protein kinase B/Akt (PKB/Akt) and phospho-to total-glycogen synthase kinase 3▒▓ (pGSK3▒▓/GSK3▒▓) ratio, as well as tau protein (Western blot) and A▓1-42 expression (immunohystochemistry, Western blot, A▓ Congo red staining) were measured and visualized in rat frontoparietal cortex (CTX) and hippocampus (HPC) one, three and six months following the STZ-icv (1-3 mg/kg) treatment. Time course of cognitive deficits was measured by Morris Water Maze Test. Data were analyzed by Cruscal-Walles ANOVA and Mann-Whitney U test (P<0.05). One month following the STZ-icv treatment insulin and IR mRNA was found significantly decreased in both regions, phosphorylated IR-( subunit expression has been unchanged (HPC) or increase (CTX), while significantly increased TK activity was found in HPC only. PKB/Akt expression and pGSK3▒▓/GSK3▒▓ ratio were found decreased (HPC) but not earlier than 3 month following the drug treatment. One month after the drug treatment only mild increase in total tau expression was observed while after three months GSK-3 related tau protein hyperpho%&34ABLNOP╗ё▌╟│Э│З│З│З│ЗmU=/h]0nh)I╗0J5БCJOJQJ^JaJmH sH /h]0nh)I╗0J5БCJOJQJ^JaJmH sH 2h]0nh)I╗0J5БCJH*OJQJ^JaJmH sH *h]0nh)I╗5БCJH*OJQJ^JmHsH*h]0nhвgE5БCJH*OJQJ^JmHsH'h]0nhвgE5БCJOJQJ^JmHsH*h]0nhвgE5Б>*CJOJQJ^JmHsH'h]0nhвgE5БCJOJQJ^JmH sH hЩvоh hAOJQJmH sH N▓ │ ┤ Ы┌ю&*К*М*ы╫╦├╫ыыпЫЗЫЕ$ ╞,Д░Д░]Д░^Д░a$gdЩvо$ ╞,Д░Д░]Д░^Д░a$gd°<л$ ╞,Д░Д░]Д░^Д░a$gdш D$a$gd]0n $ ╞,a$gd]0n$ ╞,Д░Д░]Д░^Д░a$gd]0n$ ╞,Д░Д░]Д░^Д░a$gd hA М*¤╗╝╦═╧Ў T V i j ▓ щ╘┬мЦ}h}V<#0h]0nh)I╗CJOJQJ^JaJmH nHsH tH3h]0nh)I╗CJH*OJQJ^JaJmH nHsH tH"h]0nCJOJQJ^JaJmH sH (h]0nh)I╗CJOJQJ^JaJmH sH 0h]0nh)I╗CJOJQJ^JaJmH nH sH tH *h]0nCJOJQJ^JaJmH nH sH tH +h]0nh)I╗CJH*OJQJ^JaJmH sH "h]0nCJOJQJ^JaJmH sH (h]0nh)I╗CJOJQJ^JaJmH sH ,h]0nh)I╗0JCJOJQJ^JaJmH sH  ▓ Т Ш а ░ ╩ Ї °  Z p а в д ╢ ║ ╠  " $ ы╪┼╪┼╪┼╪┼╪┼╪┼▓ЯМu^Gu-h]0nhЩvоB*CJOJQJ^JmH phsH -h]0nh╣J5B*CJOJQJ^JmH phsH -h]0nh^ТB*CJOJQJ^JmH phsH $h]0nh∙fПCJOJQJ^JmH sH $h]0nh&}щCJOJQJ^JmH sH $h]0nh╣J5CJOJQJ^JmH sH $h]0nh^ТCJOJQJ^JmH sH $h]0nh hACJOJQJ^JmH sH 'h]0nhвgE5БCJOJQJ^JmH sH $ N \ К Ю ╨ ┌ ш 2 \ t ╩ ь Є 18AEbopВЩЫ:▓ш╤║╤║╤║зФзБФзБзБзБзБзnБnБ[H[$h]0nhЩvоCJOJQJ^JmH sH $h]0nhС>╜CJOJQJ^JmH sH $h]0nh&}щCJOJQJ^JmH sH $h]0nh∙fПCJOJQJ^JmH sH $h]0nh hACJOJQJ^JmH sH $h]0nhБПCJOJQJ^JmH sH -h]0nh5КB*CJOJQJ^JmH phsH -h]0nh╣J5B*CJOJQJ^JmH phsH -h]0nh∙fПB*CJOJQJ^JmH phsH ▓║hpДЖ╕ЎCtЧЯ┘]^╝┌Ё$.$>$║$ы╪┼▓┼╪┼╪ЯМ▓МycyPyPNPy;$h]0nh:>CJOJQJ^JmH sH U$h]0nhк'oCJOJQJ^JmH sH * jbЁh]0nhш DCJOJQJ^JmH sH $h]0nhш DCJOJQJ^JmH sH $h]0nh hACJOJQJ^JmH sH $h]0nh∙fПCJOJQJ^JmH sH $h]0nhЩvоCJOJQJ^JmH sH $h]0nhБПCJOJQJ^JmH sH $h]0nhС>╜CJOJQJ^JmH sH 'h]0nhС>╜CJH*OJQJ^JmH sH sphorylation was found in HPC. A▓-like congophilic aggregates in meningeal capillaries and A▓1-42 intracellular aggregates were found not earlier than 3 months after STZ-icv treatment and were followed by A▓1-42-formed primitive plaques in HPC and cortical region six months after STZ-icv treatment. Cognitive deficits were found as early as 2 weeks after STZ-icv treatment. STZ-icv treatment induced modeling of sAD provided convincing evidence that instead of A▓ pathology, imbalance in IR signaling cascade phosphorylation/dephosphorylation and insulin resistant brain state could be a pathological core in generation of sAD, an early event which in the course of disease leads to development of AD neuropathological hallmarks, A▓ plaques and tau protein hyperphosphorylation. Supported by Croatian MZOS (108-1080003-0020) and DAAD. ║$┬$N%А%Ъ%Ю%ж%T&ю&2'8'Ж'Ц(Ё()|)*И*К*М*ы╪┼╪┼▒┼╪Ю┼ЮПАПАПl\Qh╬%gh╬%gOJQJh]0nh°<л6БCJOJQJ^J'h]0nh°<л6БCJOJQJ^JmH sH h]0nhbOїCJOJQJ^Jh]0nhЩvоCJOJQJ^J$h]0nhЩvоCJOJQJ^JmH sH 'h]0nh°<лCJH*OJQJ^JmH sH $h]0nh°<лCJOJQJ^JmH sH $h]0nh:>CJOJQJ^JmH sH 'h]0nh:>CJH*OJQJ^JmH sH ,1Рh░В. ░╞A!░Й"░Й#РЙ$РЙ%░░─░─ Р─Ь@@ё @ ╬%gNormalCJ_HaJmHsHtHDA@Є бD Default Paragraph FontRiє │R  Table NormalЎ4╓ l4╓aЎ (kЇ ┴(No List2B@Є2 ╬%g Body TextaJ*W@в* )I╗Strong5Б\Б3 .    N▓│┤O╨d · 2 5 Ш0ААШ0ААШ0ААxШ0ААШ0ААxШ0ААШ0ААШ0АА АШ0ААШ0ААШ0ААШ0АА▓d 2 5 @0А @0бHЕЪ@0ААб 0бР@│╗▓ $ ▓║$М* М* М* $%&(2346@ABDKLM)1<LTV^╧╓▌▀GXтё ЪЭкм╗ущь #дк┬╚╦╬╘╫▌фў .1auЕЗ└╬!Щзья  AO┘▄ЦЩ┘▄х∙    . 7 Ч Ъ U X h k К Н ░ · 5 M· 1 5 3Е╝┼O9НХ╨╒d 5 5   Melita Salkovicх:>в2*+╣J5 hAш DвgEЙRM=P╬%g]0nк'o5КБП∙fП^Т┐ УЄQд°<лЩvо▒2╗)I╗С>╜.┐Ў р&}щbOї ¤Gq¤ @d┤┤┤ЎЎээ3 0@0 0 0@00$@00$  Unknown            GРюЗz А Times New Roman5РАSymbol3&Рю Зz А Arial7&Рю З ЯVerdana"qИЁ─й╥к╖╞√╗╖& х╥a ╥a !ЁЙЙ┤┤ББ24d- -  3ГqЁH)Ё ?т                     =P  ~A growing body of evidence implicates impairments in brain insulin signaling in early sporadic Alzheimer disease (sAD) patholoMelita SalkovicMelita Salkovic■ рЕЯЄ∙OhлС+'│┘0ЁРШ ,DP\l ДР м ╕ ─╨╪рштA growing body of evidence implicates impairments in brain insulin signaling in early sporadic Alzheimer disease (sAD) patholo grMelita SalkovicelieliNormalSMelita Salkovic13iMicrosoft Word 10.0@Юн¤@TZx╦╟@кЕЮ1═╟╥a ■ ╒═╒Ь.УЧ+,∙о0x hpМФЬд м┤╝─ ╠ WтMedicinski fakultet- { A growing body of evidence implicates impairments in brain insulin signaling in early sporadic Alzheimer disease (sAD) patholo Title ■   ■   !"#$%&'■   )*+,-./■   ¤   2■   ■   ■                                                                                                                                                                                                                                                                                                               Root Entry         └F`4w╕1═╟4А1Table        WordDocument        ..SummaryInformation(     DocumentSummaryInformation8            (CompObj            j                        ■                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           ■       └FMicrosoft Word Document MSWordDocWord.Document.8Ї9▓q